Compare POAI & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | POAI | FLGC |
|---|---|---|
| Founded | 2002 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5M | 7.6M |
| IPO Year | N/A | 2021 |
| Metric | POAI | FLGC |
|---|---|---|
| Price | $5.58 | $8.64 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 42.7K | 33.2K |
| Earning Date | 11-14-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,664,407.00 | ★ $57,609,000.00 |
| Revenue This Year | $486.27 | N/A |
| Revenue Next Year | $65.50 | $0.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 320.71 | 24.71 |
| 52 Week Low | $3.88 | $6.80 |
| 52 Week High | $45.90 | $81.90 |
| Indicator | POAI | FLGC |
|---|---|---|
| Relative Strength Index (RSI) | 47.30 | 46.44 |
| Support Level | $3.88 | $9.28 |
| Resistance Level | $6.25 | $11.17 |
| Average True Range (ATR) | 0.76 | 1.38 |
| MACD | 0.11 | 0.36 |
| Stochastic Oscillator | 79.01 | 28.42 |
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.